Crystal structure of a highly resistant hiv-1 protease clinical isolate pr10x with grl-0519 (tris-tetrahydrofuran as p2 ligand) Deposition Author(s): Wang, Y.-F. , Weber, I.T. , Wong-Sam, A.E.
Date: 2022-06-16 Method: X-RAY DIFFRACTION Resolution: 1.25 Å Organism(s): Human Immunodeficiency Virus 1 Sequences Data: 8DCH_A , 8DCH_B
Crystal structure of a highly resistant hiv-1 protease clinical isolate pr10x (inhibitor-free) Deposition Author(s): Wang, Y.-F. , Weber, I.T. , Wong-Sam, A.E.
Date: 2022-06-16 Method: X-RAY DIFFRACTION Resolution: 1.62 Å Organism(s): Human Immunodeficiency Virus 1 Sequences Data: 8DCI_A , 8DCI_B
Hiv-1 wild type protease with grl-110-19a, a chloroacetamide derivative based on darunavir as p2' group Deposition Author(s): Agniswamy, J. , Ghosh, A.K. , Wang, Y.-F. , Weber, I.T.
Date: 2022-11-02 Method: X-RAY DIFFRACTION Resolution: 1.29 Å Organism(s): Human Immunodeficiency Virus 1 Sequences Data: 8F0F_A , 8F0F_B
Hiv-1 wild type protease with grl-02519a, with n-(2,5-dimethylphenyl)-4-(pyridin-3-yl)pyrimidin-2-amine as p2-p3 group Deposition Author(s): Ghosh, A.K. , Wang, Y.-F. , Weber, I.T. , Wong-Sam, A.E.
Date: 2023-01-17 Method: X-RAY DIFFRACTION Resolution: 1.25 Å Organism(s): Human Immunodeficiency Virus 1 Sequences Data: 8FUI_A , 8FUI_B
Hiv-1 wild type protease with grl-03419a, with n-(2,5-dimethylphenyl)-4-(pyridin-3-yl)pyrimidin-2-amine as p2-p3 group and 3,5-difluorophenylmethyl as the p1 group Deposition Author(s): Agniswamy, J. , Ghosh, A.K. , Wang, Y.-F. , Weber, I.T.
Date: 2023-01-17 Method: X-RAY DIFFRACTION Resolution: 1.12 Å Organism(s): Human Immunodeficiency Virus 1 Sequences Data: 8FUJ_A , 8FUJ_B
Hiv-1 wild type protease with grl-072-17a, a substituted tetrahydrofuran derivative based on darunavir as p2 group Deposition Author(s): Agniswamy, J. , Ghosh, A.K. , Wang, Y.-F. , Weber, I.T.
Date: 2024-03-15 Method: X-RAY DIFFRACTION Resolution: 1.32 Å Organism(s): Human Immunodeficiency Virus 1 Sequences Data: 9B2H_A , 9B2H_B